1 withdrawn. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Jaw Cysts: new trials by email Literature Review of Jaw Cysts trials Research Report on Jaw Cysts
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) LDE225B, Vehicle - Basal Cell Carcinoma | Phase 2 / Phase 3 | Withdrawn | Novartis Pharmaceuticals | 2017-05-05 |
Basal Cell Nevus Syndrome (1) · Carcinoma, Basal Cell (1)
Abnormalities, Multiple (1) · Bone Cysts (1) · Bone Diseases (1) · Bone Diseases, Developmental (1) · Carcinoma (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Cysts (1) · Genetic Diseases, Inborn (1) · Jaw Diseases (1) · Musculoskeletal Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Basal Cell (1)
Belgium (1) · Canada (1) · Czechia (1) · Finland (1) · Germany (1) · Greece (1) · Italy (1) · Spain (1) · Switzerland (1) · United Kingdom (1)